FeesSafety
Pluang+

Burford Capital prices $300M senior secured notes to refinance 2028 debt.

Company Fundamentals
14 Sep 2026, 23:55 WIB
PRNewsWire
View Source
Neutral
Burford Capital prices $300M senior secured notes to refinance 2028 debt.

Burford Capital has priced a private offering of $300 million in 8.000% senior secured notes due 2029 through its subsidiary. The proceeds will be used to redeem its 6.250% senior notes due 2028, improving its debt maturity profile. The offering is expected to close on September 17, 2026, and is targeted at qualified institutional buyers and non-US persons. This move helps Burford manage its debt more efficiently while maintaining secured financing backed by its assets.

Burford Capital's recent private offering of $300 million in senior secured notes is notable in the current financial landscape. For readers following Financials-sector US stocks, here is Pluang's market snapshot as of Sep 15, 2026 03:21 WIB: out of 74 priced stocks, 30 rose and 44 fell. Notable movers include Morgan Stanley at USD 206.94 down 3.47%, Barclays PLC at USD 25.84 down 3.24%, and Bank of New York Mellon Corp at USD 157.66 down 3.07%.

More News

SI-BONE Q3 revenue rises 15% to $55.7M; new Onyx device expands market to $5B

SI-BONE Q3 revenue rises 15% to $55.7M; new Onyx device expands market to $5B

SI-BONE reported a 15% increase in third-quarter 2026 revenue to $55.7 million, driven by growing adoption of its surgical implants. The launch of the iFuse Granite Onyx device, approved by the FDA, expands the company's addressable market to $5 bill...

Company Fundamentals
Bullish
16 minutes ago
Nvidia, Coherent, and Dell report strong AI-driven growth despite recent stock drops.

Nvidia, Coherent, and Dell report strong AI-driven growth despite recent stock drops.

Nvidia, Coherent, and Dell Technologies all supply key components for AI infrastructure and have reported strong revenue growth despite significant stock price declines. Nvidia's data center revenue rose 21% sequentially, with a fiscal Q4 revenue for...

Bullish
30 minutes ago
BridgeBio's Attruby revenue soars 134% YoY; FDA decision for BBP-418 due Nov 27

BridgeBio's Attruby revenue soars 134% YoY; FDA decision for BBP-418 due Nov 27

BridgeBio reported a 134% year-over-year increase in net product revenue for Attruby, reaching $253.2 million in Q3 2026, driven by new patients starting treatment for transthyretin amyloid cardiomyopathy. The company anticipates an FDA decision on N...

Company Fundamentals
Bullish
58 minutes ago
Altria raises dividends for 57 years but faces declining cigarette sales and high payout risks.

Altria raises dividends for 57 years but faces declining cigarette sales and high payout risks.

Altria Group has increased its dividends for 57 consecutive years, maintaining a strong yield of 5.9%, well above the S&P 500 average. However, the company's cigarette sales volumes continue to decline, with a 2.8% drop in cigarette volume this year ...

Company Fundamentals
Neutral
59 minutes ago
Everforth's Q3 revenue tops $1B; cybersecurity bookings surge 40% amid rising AI adoption.

Everforth's Q3 revenue tops $1B; cybersecurity bookings surge 40% amid rising AI adoption.

Everforth reported $1.03 billion in revenue for Q3 2026, surpassing company guidance. The firm sees enterprise software as the key channel for AI deployment, with strong growth in cybersecurity and risk bookings, up over 40% year-to-date due to incre...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App